181 related articles for article (PubMed ID: 24000244)
1. Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.
Poklis JL; Nanco CR; Troendle MM; Wolf CE; Poklis A
Drug Test Anal; 2014; 6(7-8):764-9. PubMed ID: 24000244
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS/MS in case of severe intoxications.
Wiergowski M; Aszyk J; Kaliszan M; Wilczewska K; Anand JS; Kot-Wasik A; Jankowski Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1041-1042():1-10. PubMed ID: 27992785
[TBL] [Abstract][Full Text] [Related]
3. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS
Caspar AT; Brandt SD; Stoever AE; Meyer MR; Maurer HH
J Pharm Biomed Anal; 2017 Feb; 134():158-169. PubMed ID: 27915193
[TBL] [Abstract][Full Text] [Related]
4. Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.
Nisbet LA; Venson R; Wylie FM; Scott KS
J Anal Toxicol; 2017 Jul; 41(6):559-565. PubMed ID: 28830123
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
Boumrah Y; Humbert L; Phanithavong M; Khimeche K; Dahmani A; Allorge D
Drug Test Anal; 2016 Feb; 8(2):248-56. PubMed ID: 26382567
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.
Poklis JL; Charles J; Wolf CE; Poklis A
Biomed Chromatogr; 2013 Dec; 27(12):1794-800. PubMed ID: 23893863
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
[TBL] [Abstract][Full Text] [Related]
8. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.
Poklis JL; Clay DJ; Poklis A
J Anal Toxicol; 2014 Apr; 38(3):113-21. PubMed ID: 24535338
[TBL] [Abstract][Full Text] [Related]
10. A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.
Kinyua J; Negreira N; Ibáñez M; Bijlsma L; Hernández F; Covaci A; van Nuijs AL
Anal Bioanal Chem; 2015 Nov; 407(29):8773-85. PubMed ID: 26396082
[TBL] [Abstract][Full Text] [Related]
11. Experimental Study on the Postmortem Redistribution of the Substituted Phenethylamine, 25B-NBOMe.
Shintani-Ishida K; Saka K; Nakamura M; Yoshida KI; Ikegaya H
J Forensic Sci; 2018 Mar; 63(2):588-591. PubMed ID: 28643397
[TBL] [Abstract][Full Text] [Related]
12. Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
Gee P; Schep LJ; Jensen BP; Moore G; Barrington S
Clin Toxicol (Phila); 2016; 54(2):141-6. PubMed ID: 26621342
[TBL] [Abstract][Full Text] [Related]
13. Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.
Tang MH; Ching CK; Tsui MS; Chu FK; Mak TW
Clin Toxicol (Phila); 2014 Jun; 52(5):561-5. PubMed ID: 24779864
[TBL] [Abstract][Full Text] [Related]
14. Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.
Poklis JL; Devers KG; Arbefeville EF; Pearson JM; Houston E; Poklis A
Forensic Sci Int; 2014 Jan; 234():e14-20. PubMed ID: 24215811
[TBL] [Abstract][Full Text] [Related]
15. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
[TBL] [Abstract][Full Text] [Related]
16. [The detection of the 25B-NBOMe derivative of phenylethylamine in the biological material].
Barsegyan SS; Kiryushin AN; Eroshchenko NN; Tuaeva NO; Nosyrev AE; Kirilyuk AA
Sud Med Ekspert; 2019; 62(2):34-39. PubMed ID: 31213590
[TBL] [Abstract][Full Text] [Related]
17. Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014.
Shanks KG; Sozio T; Behonick GS
J Anal Toxicol; 2015 Oct; 39(8):602-6. PubMed ID: 26378133
[TBL] [Abstract][Full Text] [Related]
18. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
Laskowski LK; Elbakoush F; Calvo J; Exantus-Bernard G; Fong J; Poklis JL; Poklis A; Nelson LS
J Med Toxicol; 2015 Jun; 11(2):237-41. PubMed ID: 25387562
[TBL] [Abstract][Full Text] [Related]
19. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
Caspar AT; Westphal F; Meyer MR; Maurer HH
Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
[TBL] [Abstract][Full Text] [Related]
20. 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential.
Custodio RJP; Sayson LV; Botanas CJ; Abiero A; You KY; Kim M; Lee HJ; Yoo SY; Lee KW; Lee YS; Seo JW; Ryu IS; Kim HJ; Cheong JH
Addict Biol; 2020 Nov; 25(6):e12850. PubMed ID: 31749223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
